Lv1
58 积分 2021-11-25 加入
Treatment of hepatocellular carcinoma with autologous platelets encapsulating sorafenib or lenvatinib: A novel therapy exploiting tumor‐platelet interactions
1个月前
已完结
Glucose-decorated engineering platelets for active and precise tumor-targeted drug delivery
1个月前
已完结
Engineering platelets as cancer therapeutics
1个月前
已完结
Opportunities and challenges of targeting cGAS–STING in cancer
3个月前
已完结
Stochasticity in cancer immunotherapy stems from rare but functionally critical Spark T cells
5个月前
已完结
Ferritin aggregation cell engager for CAR T avidity engineering against refractory leukemias
5个月前
已完结
Agonists for cytosolic bacterial receptor ALPK1 induce antitumour immunity
5个月前
已完结
HMPL-306 in relapsed or refractory IDH1- and/or IDH2-mutated acute myeloid leukemia: A phase 1 study
6个月前
已完结
Phase 1/2a clinical trial of hESC-derived dopamine progenitors in Parkinson’s disease
7个月前
已完结
Efficacy of antisense morpholino oligomer targeted to c-myc in prostate cancer xenograft murine model and a Phase I safety study in humans
8个月前
已关闭
皖公网安备34019202002308
